SAN FRANCISCO, August 5, 2015 /PRNewswire/ --
Global cell line development market size is expected to reach USD 6.24 billion by 2022, according to a new report by Grand View Research, Inc. The Increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Increasing prevalence of autoimmune diseases and cancer are likely to increase the demand for accurate and cost effective treatment options which is expected to render a positive impact on market growth. In addition, improving healthcare infrastructure, economic development and favorable government initiatives promoting the growth of the biotechnology industry are factors contributing towards the growth of the cell line development market.
Browse full research report with TOC on "Cell Line Development Market Analysis By Product (Reagents & Media, Incubators, Centrifuges, Bioreactors, Storage Equipment, Microscopes, Accessories, Consumables), By Source (Mammalian, Non Mammalian, Insects, Amphibians), By Type Of Cells (Recombinant, Hybridomas, Continuous, Primary), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/cell-line-development-market
Ongoing R&D for stable & authentic cell lines and the introduction of technologically advanced processes such as single use bioreactor and micro bioreactor for large scale bioproduction are further expected to provide this market with lucrative future growth opportunities.
Further key findings from the study suggest:
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
For the purpose of this study, Grand View Research has segmented the Cell Line Development Market on the basis of product, source, type of cell line, application and region:
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: www.grandviewresearch.com
Read Our Blogs - mediafound.org, iamamontreal2013.com, ni2014.org
Share this article